JP2017533888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533888A5 JP2017533888A5 JP2017515768A JP2017515768A JP2017533888A5 JP 2017533888 A5 JP2017533888 A5 JP 2017533888A5 JP 2017515768 A JP2017515768 A JP 2017515768A JP 2017515768 A JP2017515768 A JP 2017515768A JP 2017533888 A5 JP2017533888 A5 JP 2017533888A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- amino acid
- seq
- binding fragment
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020002597A JP6916319B2 (ja) | 2014-09-23 | 2020-01-10 | 抗ｉｌ−２５抗体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462054167P | 2014-09-23 | 2014-09-23 | |
| US62/054,167 | 2014-09-23 | ||
| PCT/US2015/051407 WO2016049000A2 (en) | 2014-09-23 | 2015-09-22 | Anti-il-25 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020002597A Division JP6916319B2 (ja) | 2014-09-23 | 2020-01-10 | 抗ｉｌ−２５抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533888A JP2017533888A (ja) | 2017-11-16 |
| JP2017533888A5 true JP2017533888A5 (enExample) | 2018-10-25 |
| JP6694877B2 JP6694877B2 (ja) | 2020-05-20 |
Family
ID=54207847
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017515768A Active JP6694877B2 (ja) | 2014-09-23 | 2015-09-22 | 抗ｉｌ−２５抗体およびその使用 |
| JP2020002597A Active JP6916319B2 (ja) | 2014-09-23 | 2020-01-10 | 抗ｉｌ−２５抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020002597A Active JP6916319B2 (ja) | 2014-09-23 | 2020-01-10 | 抗ｉｌ−２５抗体およびその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9840557B2 (enExample) |
| EP (1) | EP3197914B1 (enExample) |
| JP (2) | JP6694877B2 (enExample) |
| KR (1) | KR102576368B1 (enExample) |
| CN (1) | CN107207589B (enExample) |
| AU (1) | AU2015321517B2 (enExample) |
| CA (1) | CA2961517C (enExample) |
| CL (2) | CL2017000703A1 (enExample) |
| CO (1) | CO2017003072A2 (enExample) |
| EA (1) | EA036658B1 (enExample) |
| IL (1) | IL251001B (enExample) |
| MA (1) | MA40106A1 (enExample) |
| MX (1) | MX2017003841A (enExample) |
| MY (1) | MY185832A (enExample) |
| PH (1) | PH12017500403A1 (enExample) |
| SG (2) | SG10201913084PA (enExample) |
| WO (1) | WO2016049000A2 (enExample) |
| ZA (1) | ZA201701663B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016049000A2 (en) | 2014-09-23 | 2016-03-31 | Regeneron Pharmaceuticals, Inc. | Anti-il-25 antibodies and uses thereof |
| KR20240052871A (ko) | 2016-04-27 | 2024-04-23 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
| CN107213463A (zh) * | 2017-05-24 | 2017-09-29 | 清华大学 | 白介素25在银屑病的发育中的作用 |
| DE102017215154A1 (de) | 2017-08-30 | 2019-02-28 | Markus Bläss | Zusammensetzung zur topischen Behandlung von nicht-Mikroorganismus-verursachten entzündlichen Haut- und Schleimhauterkrankungen |
| WO2020102935A1 (en) * | 2018-11-19 | 2020-05-28 | Suzhou Kanova Biopharmaceutical Co., Ltd. | Anti-il-25 antibodies and use thereof |
| AU2020407124A1 (en) | 2019-12-20 | 2022-07-21 | Momenta Pharmaceuticals, Inc. | Antibodies against integrin alpha 11 beta 1 |
| KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| JP2023519100A (ja) * | 2020-02-11 | 2023-05-10 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 抗ａｃｖｒ１抗体およびその使用 |
| US11365239B2 (en) | 2020-03-20 | 2022-06-21 | Tsb Therapeutics (Beijing) Co., Ltd. | Anti-SARS-COV-2 antibodies and uses thereof |
| WO2022150660A1 (en) * | 2021-01-08 | 2022-07-14 | 10X Genomics, Inc. | Antigen-binding polypeptides specific for coronaviruses and uses thereof |
| EP4413036A4 (en) * | 2021-10-05 | 2025-12-03 | Lanier Biotherapeutics Inc | MONOCLONAL ANTIBODIES DIRECTED AGAINST IL-25 AND RELATED USES |
| IL315208A (en) * | 2022-02-24 | 2024-10-01 | Sinomab Bioscience Ltd | Bispecific binding proteins against alarmins and uses thereof |
| WO2023205612A1 (en) * | 2022-04-18 | 2023-10-26 | Access Medical Systems, Ltd. | High sensitivity biolayer interferometry with enzyme amplification |
| CN116024212A (zh) * | 2022-07-29 | 2023-04-28 | 硅羿科技（上海）有限公司 | 抑制IL-25基因表达的siRNA及其应用 |
| CN119451698A (zh) * | 2023-03-31 | 2025-02-14 | 新石生物制药有限公司 | 抗il-25抗体及其使用方法 |
| WO2026067830A1 (zh) * | 2024-09-30 | 2026-04-02 | 深圳市小分子新药创新中心有限公司 | 抗il-25单域抗体及其衍生物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308236D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Dna vectors |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| ATE255131T1 (de) | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
| US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| NZ587107A (en) | 2006-06-02 | 2012-05-25 | Regeneron Pharma | High affinity antibodies to human il-6 receptor |
| GB0707505D0 (en) * | 2007-04-18 | 2007-05-30 | Medical Res Council | Antibodies against il-25 |
| GB0817891D0 (en) | 2008-09-30 | 2008-11-05 | Medical Res Council | Antibodies against il-25 |
| LT2552961T (lt) | 2010-03-30 | 2018-02-12 | Janssen Biotech, Inc. | Humanizuoti il-25 antikūnai |
| WO2012097126A2 (en) * | 2011-01-13 | 2012-07-19 | The University Of Maryland, Baltimore | Il-25 treatment of obesity and metabolic disorders |
| ES2685553T3 (es) * | 2012-06-12 | 2018-10-09 | Orega Biotech | Antagonistas de isoformas de IL-17 y sus usos |
| WO2016049000A2 (en) | 2014-09-23 | 2016-03-31 | Regeneron Pharmaceuticals, Inc. | Anti-il-25 antibodies and uses thereof |
-
2015
- 2015-09-22 WO PCT/US2015/051407 patent/WO2016049000A2/en not_active Ceased
- 2015-09-22 SG SG10201913084PA patent/SG10201913084PA/en unknown
- 2015-09-22 MY MYPI2017700743A patent/MY185832A/en unknown
- 2015-09-22 MX MX2017003841A patent/MX2017003841A/es unknown
- 2015-09-22 EP EP15771489.0A patent/EP3197914B1/en active Active
- 2015-09-22 CA CA2961517A patent/CA2961517C/en active Active
- 2015-09-22 SG SG11201701712WA patent/SG11201701712WA/en unknown
- 2015-09-22 MA MA40106A patent/MA40106A1/fr unknown
- 2015-09-22 US US14/861,320 patent/US9840557B2/en active Active
- 2015-09-22 JP JP2017515768A patent/JP6694877B2/ja active Active
- 2015-09-22 CN CN201580063385.9A patent/CN107207589B/zh active Active
- 2015-09-22 AU AU2015321517A patent/AU2015321517B2/en active Active
- 2015-09-22 EA EA201790441A patent/EA036658B1/ru unknown
- 2015-09-22 KR KR1020177009048A patent/KR102576368B1/ko active Active
-
2017
- 2017-03-03 PH PH12017500403A patent/PH12017500403A1/en unknown
- 2017-03-07 IL IL251001A patent/IL251001B/en active IP Right Grant
- 2017-03-08 ZA ZA2017/01663A patent/ZA201701663B/en unknown
- 2017-03-23 CL CL2017000703A patent/CL2017000703A1/es unknown
- 2017-03-29 CO CONC2017/0003072A patent/CO2017003072A2/es unknown
- 2017-11-07 US US15/805,584 patent/US10640558B2/en active Active
-
2018
- 2018-12-14 CL CL2018003608A patent/CL2018003608A1/es unknown
-
2020
- 2020-01-10 JP JP2020002597A patent/JP6916319B2/ja active Active
- 2020-02-27 US US16/803,582 patent/US11542326B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2650767C2 (ru) | Интерлейкин-13-связывающие белки | |
| JP6916319B2 (ja) | 抗ｉｌ−２５抗体およびその使用 | |
| JP6216772B2 (ja) | 抗ｂａｆｆ−抗ｉｌ−１７二重特異性抗体 | |
| KR101773505B1 (ko) | 인간 ｉｌ-１３에 대한 결합 특이성을 갖는 항체 분자 | |
| JP6876156B2 (ja) | Ｉｌ−１７ａ及びｉｌ−１７ｆに反応するモノクローナル抗体、及びその使用 | |
| CN102307899A (zh) | 炎症、自身免疫疾病和心血管疾病的嗜酸细胞活化趋化因子-2(ccl24)抑制剂 | |
| JP2017528466A (ja) | Ｃｄ４０ｌに対するドメイン抗体を用いて自己免疫疾患を処置する方法 | |
| NZ730105B2 (en) | Anti-il-25 antibodies and uses thereof | |
| HK1256740B (en) | Interleukin -13 binding proteins | |
| HK1128495B (en) | Interleukin -13 binding proteins |